首页 > 市场调查报告书 > 医疗设备

医学影像诊断

北美临床试验影像市场预测至 2028 年 - 区域分析 - 按模式、产品（操作影像服务、影像软体、读取分析服务、试验设计和咨询服务等）和最终用户

市场调查报告书

商品编码

1360050

北美临床试验影像市场预测至 2028 年 - 区域分析 - 按模式、产品（操作影像服务、影像软体、读取分析服务、试验设计和咨询服务等）和最终用户

North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User

出版日期: 2023年07月27日 | 出版商:

The Insight Partners | 英文 124 Pages | 订单完成后即时交付

价格

简介目录图表

北美临床试验影像市场预计将从2023年的7.0494亿美元成长到2028年的10.2561亿美元；预计2023年至2028年复合年增长率为7.8%。

提供医学影像服务的 CRO 数量激增，推动北美临床试验影像市场

临床研究组织 (CRO) 透过使用高品质设施和深厚的主题专业知识提供的服务，协助临床试验的成功实施。 CRO 已开始成为临床试验行业的支柱，其高效且具有成本效益的运作使试验申办者受益。例如，平均而言，CRO 进行和完成临床试验的时间比内部活动少 30%。随着 CRO 数量的增加导致竞争加剧，其中一些企业提供专门的成像服务，从而成为成像 CRO (iCRO)。 iCRO 的一些例子包括 Keosys Medical Imaging 和 Medica Group PLC。 CRO 在成像现场鑑定、标准化影像撷取以及读取设计和标准确定等领域提供关键知识见解，从而促进整个北美临床试验成像市场的成长。

北美临床试验影像市场概况

北美临床试验影像市场分为美国、加拿大和墨西哥。美国是临床试验成像最大且成长最快的市场。该地区的市场成长归因于美国逐渐成为领先的临床研究目的地，以及越来越多的公司推出用于临床试验的创新产品。美国已成为领先的临床研究目的地。全球约一半的临床试验是在美国进行的。此外，由于成熟的医疗基础设施、快速的审批时间表、有利的监管框架以及可接受的临床试验产生的资料，大多数製药研究公司更愿意在美国进行临床试验。

北美临床试验影像市场收入及 2028 年预测（百万美元）

北美临床试验影像市场细分

北美临床试验成像市场根据模式、产品、最终用户和国家进行细分。

根据模式，北美临床试验影像市场分为断层扫描、磁振造影 (MRI)、超音波、正子断层扫描 (PET)、X 光、超音波心动图等。 2023 年，断层扫描领域占据了最大的市场。

根据产品类型，北美临床试验影像市场分为操作影像服务、影像软体、读取分析服务、试验设计和咨询服务等。 2023 年，营运影像服务领域占据最大的市场份额。

根据最终用户，北美临床试验影像市场分为合约研究组织（CRO）、製药和生物技术公司、学术和研究机构等。合约研究组织 (CRO) 领域在 2023 年占据最大的市场份额。

根据国家/地区，市场分为美国、加拿大和墨西哥。 2023 年，美国占据市场份额主导地位。

BioTelemetry Inc、Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、Medpace Holdings Inc、VIDA Diagnostics Inc 和 WCG Clinical Inc 是北美临床试验成像市场的领先公司。

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.

North America Clinical Trial Imaging Market Overview

The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.

North America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)

North America Clinical Trial Imaging Market Segmentation

The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.

Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.

Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.

Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.

Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.

BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trial imaging market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 North America Market Segmentation
- 1.3.1 North America Clinical Trial Imaging Market - by Modality
- 1.3.2 North America Clinical Trial Imaging Market - by Offering
- 1.3.3 North America Clinical Trial Imaging Market - by End User
- 1.3.4 North America Clinical Trial Imaging Market - by Country

2. North America Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Clinical Trial Imaging Market - Market Landscape

4.1 Overview
- 4.1.1 North America PEST Analysis
4.2 Expert Opinion

5. North America Clinical Trial Imaging Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. North America Clinical Trial Imaging Market

6.1 North America Clinical Trial Imaging Market Revenue Forecast and Analysis

7. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

7.1 Overview
7.2 North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

8.1 Overview
8.2 North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
  - 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Clinical Trial Imaging Market - Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Calyx Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 ICON PLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 VIDA Diagnostics Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WCG Clinical Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BioTelemetry Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medical Metrics Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medpace Holdings Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 IXICO plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 12. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Clinical Trial Imaging Market Segmentation
Figure 2. North America Clinical Trial Imaging Market, by Country
Figure 3. North America Clinical Trial Imaging Market Overview
Figure 4. North America Clinical Trial Imaging Market, By Modality
Figure 5. North America Clinical Trial Imaging Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 9. Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 17. Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 23. Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 29. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)